Listen to MS News Today’s Exclusive Interview With Roche on Ocrelizumab

Isaura Santos avatar

by Isaura Santos |

Share this article:

Share article via email

Dr. Peter Chin, a renowned neurologist and Principal Medical Director of Global Neuroscience Development at Genentech, a member of the Roche Group, participated in an exclusive interview with Multiple Sclerosis News Today correspondent Dr. Ana de Barros on the company’s promising multiple sclerosis (MS) therapy ocrelizumab.

Read the article: http://bit.ly/1JZddMJ

Print This Page

About the Author

Isaura Santos avatar
Isaura Santos Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

Tags

ECTRIMS 2015, ocrelizumab, Roche

Recent Posts

Dancing Doodle

Did you know some of the news and columns on Multiple Sclerosis News Today are recorded and available for listening on SoundCloud? These audio news stories give our readers an alternative option for accessing information important for them.

Listen Here

Recommended reading